Cite Filings / FTH / 0001193125-22-110334

Feed Companies Filings Check

Sign in

8-K

Current Report

Faeth Therapeutics, Inc. Filed 2022-04-20 Acc 0001193125-22-110334

Regulation FD disclosure

Item 7.01 Regulation FD disclosure

From the SEC's structured data for this filing

Documents 1

8-K Current Report , d281330d8k.htm

Around this filing

2022-05-10 8-K Results of operations
2022-04-21 4/A Director bought 9,500 shares at $14.34 ($136,230)
2022-04-21 4/A Director bought 752 shares at $19.75 ($14,852)
2022-04-21 4/A 10% owner bought 9,500 shares at $14.34 ($136,230)
2022-04-21 4/A 10% owner bought 752 shares at $19.75 ($14,852)
2022-04-20 8-K Regulation FD disclosure
2022-03-10 8-K Results of operations

Link to a passage

Paste a passage to link it

At least 12 characters, not counting spaces, so the link points to one passage.

External

SEC EDGAR (opens in new tab)
SEC Structured Data (opens in new tab)

Loading d281330d8k.htm…

Connection lost

Reconnecting…

Cite Filings isn't responding

Reconnecting…